Johannes Roebers has over 25 years leadership experience in site leadership, R&D leadership, major project leadership, strategy development, operations, engineering, regulatory affairs, clinical operations, and facilities across Germany, Canada, USA, and Ireland in small, medium, and large biopharmaceutical companies. Prior to founding Cilatus, Johannes was a cofounding executive of Prothena Bioscience Inc., South San Francisco, CA and served as Executive Vice President and Head of Operations and Site Manager for Elan Pharmaceuticals, Dublin Ireland. Johannes also held senior leadership and management positions at Genentech, Biogen-IDEC, IDEC Pharmaceuticals, and Bayer.
Johannes earned his Ph.D. in Chemical Engineering from Clemson University, South Carolina, USA and his Dipl.-Ing. Verfahrenstechnik from RWTH in Aachen, Germany.
In Cilatus, Johannes serves as the main contact to clients and especially enjoys developing fully integrated CMC development, regulatory, and manufacturing strategies. He is a thought leader in virtualization and outsourcing in the biopharmaceutical development and manufacturing area and enjoys staying involved in engineering, construction and validation projects.